Core Viewpoint - Baiyunshan's subsidiary, Guangzhou Baiyunshan Hanfang Modern Pharmaceutical Co., Ltd., has received approval from the National Medical Products Administration for the listing application of structured triglycerides as a chemical raw material drug, indicating compliance with national drug review technical standards and enhancing the company's product competitiveness in the market [1] Group 1 - The approval allows Baiyunshan Hanfang to produce and sell structured triglycerides, which are key raw materials for various nutritional injection formulations [1] - Structured triglycerides are suitable for patients who cannot, insufficiently, or are contraindicated from oral or enteral nutrition, providing parenteral nutrition supplementation of fats [1] - The approval is expected to enrich Baiyunshan Hanfang's medicinal lipid raw material product offerings, further enhancing the company's market competitiveness in lipid raw materials [1] Group 2 - The approval of the chemical raw material drug listing does not have a significant impact on the company's current performance [1]